tyrosine kinase inhibitor
C43617
concept
A tyrosine kinase inhibitor is a drug that blocks the activity of tyrosine kinases—enzymes involved in cell signaling pathways—to prevent uncontrolled cell growth and proliferation, commonly used in cancer therapy.
Observed surface forms (6)
- protein kinase inhibitor ×6
- HER2 inhibitor ×3
- RET inhibitor ×1
- TRK inhibitor ×1
- anaplastic lymphoma kinase inhibitor ×1
- small-molecule tyrosine kinase inhibitor ×1
Instances (15)
- Tagrisso
- larotrectinib
- selpercatinib
- LOXO-292
- Vitrakvi
- Retevmo
- LOXO-195 via concept surface "TRK inhibitor"
- Gleevec
- Tasigna
- Alecensa via concept surface "protein kinase inhibitor"
- acalabrutinib via concept surface "protein kinase inhibitor"
- zanubrutinib via concept surface "protein kinase inhibitor"
- lapatinib
- neratinib
- tucatinib via concept surface "small-molecule tyrosine kinase inhibitor"